California Gov. Gavin Newsom (D) on Monday (Oct. 7) signed the nation’s first state law discouraging settlements between drug makers that delay generic competition, sparking strong opposition from the generic drug lobby, which alleges the law is unconstitutional. Meanwhile, federal legislation on pay-for-delay agreements has stalled. Consumer advocacy group California Health Access called the law the “biggest prescription drug price bill of the year” in the state, but still called for federal action. Legislation banning pay-for-delay agreements was left out...